Oncology News

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code SK006, as the only FDA-approved companion diagnostic indicated to aid in identifying patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma (EOC), whose tumors express PD-L1 and who may be eligible for treatment with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy. PD-L1 IHC 22C3 pharm...

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved Optune Pax® for the treatment of adult patients with locally advanced pancreatic cancer concomitant with gemcitabine and nab-paclitaxel. “In the Phase 3 PANOVA-3 trial, treatment with Optune Pax resulted in a statistically significant improvement in overall survival without adding to the systemic side effects commonly associated with existing therapies. It also s...

SAN FRANCISCO--(BUSINESS WIRE)--Kirk Herbstreit, Emmy Award‑winning college football analyst for ESPN/ABC and NFL analyst for Thursday Night Football on Amazon Prime Video, received the 2026 Pat Summerall Award on Thursday, Feb. 5. The award was presented at the Legends for Charity® dinner benefitting the lifesaving mission of St. Jude Children’s Research Hospital®: Finding cures. Saving children.® The exclusive red carpet event raised $1.7M with the help of 400 supporters, broadcasters and spo...

PALO ALTO, Calif.--(BUSINESS WIRE)--Valar Labs, a leader in computational histology and precision oncology, today announced the publication of a major study in the Journal of Clinical Oncology (JCO), a premier, peer-reviewed medical journal published by the American Society of Clinical Oncology. The report, appearing in the Journal of Clinical Oncology (JCO), uses Valar Labs’ proprietary AI algorithm that analyzes standard H&E-stained pathology slides—universally available for almost every...

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera to Present at Upcoming Investor Conferences in March and April 2026...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer and inflammatory and autoimmune diseases, announced that its management team will host a conference call and webcast on Wednesday, February 25th, 2026 at 1:30 PM PT / 4:30 PM ET to discuss details of the Company’s financial results and pipeline update for the quarter and year ended De...

SAN DIEGO--(BUSINESS WIRE)--Curebound, a philanthropic organization that funds innovative cancer research, adds five prominent business leaders to Board...

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR), a global leader in radiation detection, measurement, analysis and monitoring solutions for the nuclear, medical, defense and research end markets, today announced three new leadership appointments supporting the company’s continued focus on safety, innovation, operational excellence and long-term growth. Chief Nuclear Officer: Tighe Smith Mirion has promoted Tighe Smith to the newly created role of Chief Nuclear Officer. Reporting to Thomas Logan, M...

LOS ANGELES--(BUSINESS WIRE)--The Stephenson Global Prize, a $1 million award for innovation in pancreatic cancer research, has opened its second call for nominations. Awarded annually, the Prize recognizes visionary scientific leaders whose work is fundamentally changing the trajectory of pancreatic cancer research. Nominations are now open through May 1, 2026. The Stephenson Global Prize is part of a philanthropic program launched by A. Emmet Stephenson Jr., and Tessa Stephenson Brand. Their...

NEW YORK--(BUSINESS WIRE)--Flatiron Health is pleased to announce three significant appointments to its Executive Team, reflecting the critical, enterprise-level responsibilities these leaders have assumed and the company’s evolving direction. Michael Bierl will serve as Chief Business Officer, Allison Candido will serve as Chief Technology Officer, and Kate Estep will serve as Chief Product Officer. With decades of combined experience, Bierl, Candido, and Estep bring the leadership and experti...